Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 51: 2001-2002, 2005; 10.1373/clinchem.2005.056382
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hill, M. D.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2005;51:2001-2002.)
© 2005 American Association for Clinical Chemistry, Inc.

Editorials

Diagnostic Biomarkers for Stroke: A Stroke Neurologist’s Perspective

Michael D. Hill

Univeristy of Calgary, Foothills Medical Centre, Rm 1242A, Calgary, Alberta, T2N 2T9 Canada

The first 20% of the full text of this article appears below.

Since 2003, four articles on stroke biomarkers as potential diagnostic tests have been published in Clinical Chemistry (1)(2)(3)(4). Each has described an initial foray into attempting to find a holy grail in clinical stroke—a blood test for stroke—and each has provided early exciting results that suggest that we may yet welcome a new era of stroke diagnostics into the clinical realm.

Human stroke is remarkably heterogeneous. Stroke varies widely in severity with a majority of strokes being mild. Stroke comes in 3 major types. In North America and Europe, ischemic stroke comprises 85% of all strokes, intracerebral hemorrhage 8%, and subarachnoid hemorrhage 7%. These ratios differ in Asia with up to 30% of strokes occurring as intracerebral hemorrhages. For the neurologist, stroke is relatively easy to diagnose clinically. It is the most common cause of a sudden acute neurologic deficit in both adults and children. Imaging is the mainstay of identifying stroke type because it is not possible to distinguish ischemia from hemorrhage reliably on clinical grounds alone.

A brain computed tomographic scan rules in an intracerebral hemorrhage or subarachnoid hemorrhage and in many cases rules . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.